Takeda Pharmaceuticals

better health for people and a brighter future for the world

YouTube

By loading the video, you agree to YouTube's privacy policy.
Learn more

Load video

Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.

 

AM SECTOR

Takeda Pharmaceuticals

Thurgauerstrasse 130, 8152 Opfikon, Zürich, Switzerland

dominic.duda@takeda.com

MGA Network

member since 01.12.2021

Membership Motivation

Takeda's vision is to set up a new and future-oriented supply chain for format and spare parts that fit the pharmaceutical industry environment's properties on a holistic basis. Strong collaboration and partnerships within a well-known network are the keys to success. We are happy to lead the new pharmaceutical sector within MGA.

Network Contribution

3D printing expertise in pharmaceutical environment for manufacturing equipment
format and spare parts.